Drug Database
Back to search

Finland· FI-REL-REL62102

Wainzua

A eplontersen product containing eplontersen, registered in Finland by AstraZeneca AB. The same ATC class is registered in 13 of our 19 countries.

ATC N07XX21

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedWainzuaATCN07XX21REGISTER NO.FI-REL-REL62102PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about eplontersenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Eplontersen is registered in 13 of 19 countries.

Countries holding a registration under ATC N07XX21 (eplontersen), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose
Search eplontersen products by name

Eplontersen · ATC N07XX21

13 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

Fimea (Finland)
Active substance
Eplontersen
Manufacturer
AstraZeneca AB
Country
Finland (FI)
ATC code
N07XX21
ATC class
Eplontersen
Defined daily dose
1.5 mg, P
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Eplontersen in 7 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All eplontersen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/56d2fee1-3863-42d8-abbb-b334d4305a69
GET /v1/drugs/56d2fee1-3863-42d8-abbb-b334d4305a69?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": null,
  "form": "injektioneste, liuos",
  "route": "Ihon alle",
  "ddd_unit": null,
  "strength": "45 mg",
  "atc_label": "eplonterseeni",
  "ma_number": null,
  "auth_status": "Myyntilupa myönnetty",
  "eu_ma_number": "EU/1/24/1875/001",
  "fimea_rel_id": "REL62102",
  "authorised_at": "2025-03-06"
}
API referenceMCP serverPlans

See everything about eplontersen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console